FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Medtronic | defibrillator

St. Jude lead punctures patients' hearts

Tools

Poor defibrillator patients. First they got jolted by Medtronic's Fidelis lead. Now, a St. Jude Medical connection wire is perforating their hearts. According to the medical journal PACE, four patients' hearts were punctured by the leads on their Riata defibrillators. Not surprisingly, St. Jude's stock fell 4 percent on the news.

St. Jude is striking back with stats about Riata's safety. The company has submitted its own article to PACE (Pacing and Clinical Electrophysiology), citing "new information" that the rate of performation problems is "below or at the low end" of what's been seen with other leads.

Some stock analysts called the story "old news." A study published in April had already showed that patients with the Riata product experienced significantly more perforations than those with Medtronic's product did. More data needed? Sounds like it.

- see this release from St. Jude
- read the report from the Houston Chronicle
- read about St. Jude's response at TwinCities.com

Related Articles:
St. Jude gets OK for radio-frequency heart implants. Report
Medtronic withdraws defibrillator part. Report
Medtronic sued over faulty defibrillator parts. Report
Patients face defibrillator recalls. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Medtronic   defibrillator